Skinbiotherapeutics brings in new audit chair, launches forensic review
20th Feb 2026 07:55
(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that it has appointed Alyson Levett as a new non‑executive director and chair of the audit committee, with responsibility for overseeing the ongoing investigation into the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.
Read moreSkinBioTherapeutics dives on warning of major FY25 revenue restatement
16th Feb 2026 08:53
(Sharecast News) - Life sciences company SkinBioTherapeutics traded sharply lower early on Monday after revealing an internal investigation had raised serious concerns over the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.
Read moreSkinBio Therapeutics CEO resigns
13th Feb 2026 07:56
(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that chief executive Stuart Ashman has resigned, having been suspended by the board pending an investigation into matters relating to his conduct.
Read moreSkinBioTherapeutics revenue rises fourfold, still misses forecasts
14th Aug 2025 13:48
(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.
Read moreSkinBioTherapeutics inks Superdrug deal, raises £4.1m
16th Jun 2025 16:14
(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.
Read moreSkinBioTherapeutics shares jump on acquisition of topical cream maker
11th Oct 2024 08:41
(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.
Read moreSkinBioTherapeutics reports positive results from testing with Croda
19th Sep 2024 13:13
(Sharecast News) - SkinBioTherapeutics announced on Thursday that final testing of its 'SkinBiotix' technology by Croda Beauty Care had yielded positive results, paving the way for commercialisation.
Read moreSkinBioTherapeutics secures £1.56m from new investors
2nd Aug 2024 14:57
(Sharecast News) - SkinBioTherapeutics announced on Friday that it has secured an investment of £1.56m on Friday, removing any uncertainty around its medium-term financing.
Read moreSkinBioTherapeutics reports better-than-expected full-year trading
29th Jul 2024 11:53
(Sharecast News) - Skin health-focussed life science company SkinBioTherapeutics reported better-than-expected trading results for the 12 months ended 30 June on Monday, boosted by the acquisition of Dermatonics and the continued growth of its AxisBiotix-Ps product.
Read moreSkinBioTherapeutics reports positive interim acne study findings
27th Feb 2024 15:44
(Sharecast News) - Life science company SkinBioTherapeutics reported encouraging interim findings from its ongoing AxisBiotix acne food supplement study featuring its lead formulation on Tuesday.
Read moreSkinBioTherapeutics finalises acquisition of Dermatronics
26th Jan 2024 16:04
(Sharecast News) - SkinBioTherapeutics announced on Friday that it has finalised the acquisition of Dermatonics, known for its topical and dermatological products within the skincare and wound care sector.
Read moreSkinBioTherapeutics launches new consumer study into acne
25th Oct 2023 09:08
(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".
Read moreSkinBioTherapeutics gets France approval for psoriasis supplement
15th Sep 2023 10:11
(Sharecast News) - SkinBioTherapeutics has been given the green light by French regulators to introduce its food supplement, AxisBiotix-Ps, into the French market, it announced on Friday.
Read moreSkinBioTherapeutics selects probiotic blends for acne study
5th Sep 2023 12:44
(Sharecast News) - Skin health specialist SkinBioTherapeutics updated the market on its decision on the probiotic blends to be used in a consumer volunteer study aimed at acne treatment on Tuesday.
Read moreSkinBioTherapeutics launching psoriasis supplement in Italy
21st Jun 2023 17:00
(Sharecast News) - Skin health specialist SkinBioTherapeutics has received regulatory approval to introduce 'AxisBiotix-Ps' - a food supplement designed to alleviate the symptoms associated with psoriasis - into the Italian market, it announced on Wednesday.
Read more